H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 10 250 KRW -1.25% Market Closed
Market Cap: 182.1B KRW

Intrinsic Value

The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is 15 143.78 KRW. Compared to the current market price of 10 250 KRW, Hana Pharm Co Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15 143.78 KRW
Undervaluation 32%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hana Pharm Co Ltd

Hana Pharm Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hana Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hana Pharm Co Ltd
KRX:293480
KR
Pharmaceuticals
Market Cap
177.3B KRW
IPO
Oct 2, 2018
KR
Pharmaceuticals
Market Cap
177.3B KRW
IPO
Oct 2, 2018
Price
â‚©false
EPS
â‚©false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hana Pharm Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Hana Pharm Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hana Pharm Co Ltd

Current Assets 100.8B
Cash & Short-Term Investments 5.2B
Receivables 43B
Other Current Assets 52.7B
Non-Current Assets 250.2B
Long-Term Investments 69.8B
PP&E 158.6B
Intangibles 15.5B
Other Non-Current Assets 6.4B
Efficiency

Free Cash Flow Analysis
Hana Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hana Pharm Co Ltd

Revenue
225.3B KRW
Cost of Revenue
-84B KRW
Gross Profit
141.3B KRW
Operating Expenses
-116.1B KRW
Operating Income
25.2B KRW
Other Expenses
-3.9B KRW
Net Income
21.3B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hana Pharm Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive 3-Years Revenue Growth
Positive Net Income
52/100
Profitability
Score

Hana Pharm Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hana Pharm Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Low D/E
Short-Term Solvency
79/100
Solvency
Score

Hana Pharm Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hana Pharm Co Ltd

Wall Street analysts forecast Hana Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hana Pharm Co Ltd is 18 360 KRW with a low forecast of 18 180 KRW and a high forecast of 18 900 KRW.

Lowest
Price Target
18 180 KRW
77% Upside
Average
Price Target
18 360 KRW
79% Upside
Highest
Price Target
18 900 KRW
84% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hana Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hana Pharm Co Ltd stock?

The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is 15 143.78 KRW.

Is Hana Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 10 250 KRW, Hana Pharm Co Ltd is Undervalued by 32%.

Back to Top